Literature DB >> 14615066

Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids.

M Carmo Barreto1, Ruy E Pinto, João D Arrabaça, M Leonor Pavão.   

Abstract

The alkaloids from Chelidonium majus L. which had a significant inhibitory effect in mitochondrial respiration were those which contain a positive charge due to a quaternary nitrogen atom, i.e., chelerythrine, sanguinarine, berberine and coptisine, both with malate+glutamate or with succinate as substrates. When malate+glutamate was used as substrate, chelerythrine and berberine, which contain methoxy groups, were particularly more active, since they had a strong effect even at low concentrations. In submitochondrial particles, berberine and coptisine had a marked inhibitory effect on NADH dehydrogenase activity but practically no effect on succinate dehydrogenase activity, whereas chelerythrine and sanguinarine inhibited more strongly succinate dehydrogenase than NADH dehydrogenase, which is in agreement with the results found for mitochondrial respiration. Protopine and allocryptopine, which did not inhibit mitochondrial respiration, strongly inhibited NADH dehydrogenase in submitochondrial particles, but had no effect on succinate dehydrogenase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615066     DOI: 10.1016/j.toxlet.2003.09.007

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  13 in total

Review 1.  Chemical biology of histone acetyltransferase natural compounds modulators.

Authors:  Fabrizio Dal Piaz; Antonio Vassallo; Osmany Cuesta Rubio; Sabrina Castellano; Gianluca Sbardella; Nunziatina De Tommasi
Journal:  Mol Divers       Date:  2011-01-01       Impact factor: 2.943

2.  Chelerythrine induces reactive oxygen species-dependent mitochondrial apoptotic pathway in a murine T cell lymphoma.

Authors:  Sanjay Kumar; Arbind Acharya
Journal:  Tumour Biol       Date:  2013-07-31

3.  Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway.

Authors:  Juan Xie; Yinyan Xu; Xinyan Huang; Yanni Chen; Jing Fu; Mingming Xi; Li Wang
Journal:  Tumour Biol       Date:  2014-10-29

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  Berberine improves glucose metabolism through induction of glycolysis.

Authors:  Jun Yin; Zhanguo Gao; Dong Liu; Zhijun Liu; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-30       Impact factor: 4.310

6.  Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.

Authors:  Xuan Xia; Jinhua Yan; Yunfeng Shen; Kuanxiao Tang; Jun Yin; Yanhua Zhang; Dongjie Yang; Hua Liang; Jianping Ye; Jianping Weng
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

7.  Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.

Authors:  Daniel Habermehl; Bernd Kammerer; René Handrick; Therese Eldh; Charlotte Gruber; Nils Cordes; Peter T Daniel; Ludwig Plasswilm; Michael Bamberg; Claus Belka; Verena Jendrossek
Journal:  BMC Cancer       Date:  2006-01-17       Impact factor: 4.430

8.  Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine.

Authors:  Jon Holy; Genelle Lamont; Edward Perkins
Journal:  BMC Cell Biol       Date:  2006-03-02       Impact factor: 4.241

9.  Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes.

Authors:  Zolikha Moazezi; Durdi Qujeq
Journal:  Jundishapur J Nat Pharm Prod       Date:  2014-04-07

Review 10.  Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses.

Authors:  Andrew Croaker; Graham J King; John H Pyne; Shailendra Anoopkumar-Dukie; Lei Liu
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.